Table 3.
Anti-candidal potency of characterized pooled saliva from the HIV− and HIV+ groups.
Saliva | Hst-5 (μg/ml) | % killing |
---|---|---|
HIV+ (M) | 4.82* | 18.62 |
HIV+ (L) | 1.1 | 0 |
HIV− (H) | 8.67* | 35.86 |
HIV− (M) | 5.62* | 19.31 |
HIV− (L) | 2.6 | 0 |
Experiments were performed on three separate occasions. (L) % killing was compared with rest of the groups.
P<0.05